ASX - By Stock
|
ST1 |
Re:
Ann: FY21 Results Presentation
|
|
organisation13
|
51 |
17K |
2 |
05/09/21 |
05/09/21 |
ASX - By Stock
|
51
|
17K
|
2
|
|
ASX - By Stock
|
ST1 |
Re:
Ann: FY21 Results Presentation
|
|
organisation13
|
51 |
17K |
0 |
05/09/21 |
05/09/21 |
ASX - By Stock
|
51
|
17K
|
0
|
|
ASX - By Stock
|
CDX |
Re:
CardieX subsidiary ATCOR, achieves technology milestone for world-first PPG Sensor Algorithm
|
|
organisation13
|
2 |
1.2K |
16 |
30/06/21 |
30/06/21 |
ASX - By Stock
|
2
|
1.2K
|
16
|
|
ASX - By Stock
|
CDX |
Re:
Ann: CDX's CONNEQT Signs Strategic Collaboration with LifeQ
|
|
organisation13
|
74 |
23K |
17 |
24/06/21 |
24/06/21 |
ASX - By Stock
|
74
|
23K
|
17
|
|
ASX - By Stock
|
CDX |
Re:
Ann: CDX's CONNEQT Signs Strategic Collaboration with LifeQ
|
|
organisation13
|
74 |
23K |
21 |
24/06/21 |
24/06/21 |
ASX - By Stock
|
74
|
23K
|
21
|
|
ASX - By Stock
|
CG1 |
Re:
Ann: New US$1 million order received for Activated Carbon Pellets
|
|
organisation13
|
9 |
3.1K |
0 |
16/06/21 |
16/06/21 |
ASX - By Stock
|
9
|
3.1K
|
0
|
|
ASX - By Stock
|
CDX |
Re:
Ann: Commercial Partnership with Mobvoi for New Health Smartwatch
|
|
organisation13
|
425 |
116K |
10 |
15/06/21 |
15/06/21 |
ASX - By Stock
|
425
|
116K
|
10
|
|
ASX - By Stock
|
CDX |
Re:
Ann: Commercial Partnership with Mobvoi for New Health Smartwatch
|
|
organisation13
|
425 |
116K |
10 |
13/06/21 |
13/06/21 |
ASX - By Stock
|
425
|
116K
|
10
|
|
ASX - By Stock
|
CDX |
Re:
Ann: Commercial Partnership with Mobvoi for New Health Smartwatch
|
|
organisation13
|
425 |
116K |
15 |
08/06/21 |
08/06/21 |
ASX - By Stock
|
425
|
116K
|
15
|
|
ASX - By Stock
|
EMD |
Re:
EMD Research
|
|
organisation13
|
146 |
44K |
10 |
10/05/21 |
10/05/21 |
ASX - By Stock
|
146
|
44K
|
10
|
|
ASX - By Stock
|
LEL |
Lithium Energy Limited - IPO Breakdown
|
|
organisation13
|
47 |
26K |
23 |
09/05/21 |
09/05/21 |
ASX - By Stock
|
47
|
26K
|
23
|
|
ASX - By Stock
|
CG1 |
Re:
Ann: Carbonxt raises $2.1m for pellet plant expansion
|
|
organisation13
|
15 |
4.6K |
6 |
08/05/21 |
08/05/21 |
ASX - By Stock
|
15
|
4.6K
|
6
|
|
ASX - By Stock
|
EMD |
Re:
EMD Research
|
|
organisation13
|
146 |
44K |
3 |
30/04/21 |
30/04/21 |
ASX - By Stock
|
146
|
44K
|
3
|
|
ASX - By Stock
|
CDX |
Re:
Ann: Appendix 4C and Quarterly Activities Report
|
|
organisation13
|
68 |
19K |
24 |
27/04/21 |
27/04/21 |
ASX - By Stock
|
68
|
19K
|
24
|
|
ASX - By Stock
|
CDX Biotech |
Re:
General Forum
|
|
organisation13
|
1.7K |
569K |
24 |
18/04/21 |
18/04/21 |
ASX - By Stock
|
1.7K
|
569K
|
24
|
|
ASX - By Stock
|
CDX Biotech |
Re:
General Forum
|
|
organisation13
|
1.7K |
569K |
11 |
14/04/21 |
14/04/21 |
ASX - By Stock
|
1.7K
|
569K
|
11
|
|
ASX - By Stock
|
BPH |
Re:
David Breeze in Webinar
|
|
organisation13
|
212 |
59K |
19 |
12/02/21 |
12/02/21 |
ASX - By Stock
|
212
|
59K
|
19
|
|
ASX - By Stock
|
RGT |
Re:
Ann: MGC Pharma to list on the London Stock Exchange
|
|
organisation13
|
131 |
52K |
10 |
12/02/21 |
12/02/21 |
ASX - By Stock
|
131
|
52K
|
10
|
|
ASX - By Stock
|
EMD |
Re:
EMD Research
|
|
organisation13
|
146 |
44K |
3 |
25/01/21 |
25/01/21 |
ASX - By Stock
|
146
|
44K
|
3
|
|
ASX - By Stock
|
CDX |
Re:
Technical 200dma bullish cross
|
|
organisation13
|
466 |
131K |
16 |
18/01/21 |
18/01/21 |
ASX - By Stock
|
466
|
131K
|
16
|
|
ASX - By Stock
|
EMD |
Re:
EMD Research
|
|
organisation13
|
146 |
44K |
7 |
11/01/21 |
11/01/21 |
ASX - By Stock
|
146
|
44K
|
7
|
|
ASX - By Stock
|
SPA |
Re:
Ann: Upcoming business performance updates
|
|
organisation13
|
26 |
7.4K |
5 |
05/01/21 |
05/01/21 |
ASX - By Stock
|
26
|
7.4K
|
5
|
|
ASX - By Stock
|
CDX |
Re:
SP @ 31/12/21
|
|
organisation13
|
47 |
12K |
17 |
04/01/21 |
04/01/21 |
ASX - By Stock
|
47
|
12K
|
17
|
|
ASX - By Stock
|
SPA |
Re:
Ann: Upcoming business performance updates
|
|
organisation13
|
26 |
7.4K |
8 |
02/01/21 |
02/01/21 |
ASX - By Stock
|
26
|
7.4K
|
8
|
|
ASX - By Stock
|
EMD |
Re:
EMD Research
|
|
organisation13
|
146 |
44K |
11 |
02/01/21 |
02/01/21 |
ASX - By Stock
|
146
|
44K
|
11
|
|
ASX - By Stock
|
CDX |
Re:
24Hr Monitoring is the Key.
|
|
organisation13
|
18 |
4.7K |
23 |
30/12/20 |
30/12/20 |
ASX - By Stock
|
18
|
4.7K
|
23
|
|
ASX - By Stock
|
EMD |
Re:
EMD Research
|
|
organisation13
|
146 |
44K |
4 |
28/12/20 |
28/12/20 |
ASX - By Stock
|
146
|
44K
|
4
|
|
ASX - By Stock
|
EMD |
EMD Research
|
|
organisation13
|
146 |
44K |
20 |
28/12/20 |
28/12/20 |
ASX - By Stock
|
146
|
44K
|
20
|
|
ASX - By Stock
|
SPA |
Re:
Game Over
|
|
organisation13
|
46 |
14K |
6 |
04/12/20 |
04/12/20 |
ASX - By Stock
|
46
|
14K
|
6
|
|
ASX - By Stock
|
DLM |
Re:
Ann: Market update on timing - commercial transaction
|
|
organisation13
|
31 |
6.8K |
3 |
17/11/20 |
17/11/20 |
ASX - By Stock
|
31
|
6.8K
|
3
|
|
ASX - By Stock
|
DLM |
Re:
Ann: Market update on timing - commercial transaction
|
|
organisation13
|
31 |
6.8K |
11 |
17/11/20 |
17/11/20 |
ASX - By Stock
|
31
|
6.8K
|
11
|
|
ASX - By Stock
|
CDX |
Re:
Ann: CardieX September Quarter Activity Report
|
|
organisation13
|
21 |
6.0K |
11 |
02/11/20 |
02/11/20 |
ASX - By Stock
|
21
|
6.0K
|
11
|
|
ASX - By Stock
|
SNT |
Re:
News: PXS FDA Approves Pharmaxis, Chiesi's Bronchitol As Therapy To Improve Pulmonary Function In...
|
|
organisation13
|
135 |
49K |
7 |
01/11/20 |
01/11/20 |
ASX - By Stock
|
135
|
49K
|
7
|
|
ASX - By Stock
|
SPA |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
organisation13
|
94 |
23K |
6 |
23/10/20 |
23/10/20 |
ASX - By Stock
|
94
|
23K
|
6
|
|
ASX - By Stock
|
DLM |
Re:
Ann: FTT enters agreement- Veterinary Medical Technology Pipeline
|
|
organisation13
|
149 |
38K |
7 |
18/10/20 |
18/10/20 |
ASX - By Stock
|
149
|
38K
|
7
|
|
ASX - By Stock
|
CDX |
Re:
CDX is a Mass-Market Consumer and SaaS Company
|
|
organisation13
|
10 |
3.8K |
12 |
18/10/20 |
18/10/20 |
ASX - By Stock
|
10
|
3.8K
|
12
|
|
ASX - By Stock
|
CDX |
Re:
Ann: Commercial Partnership with Mobvoi for New Health Smartwatch
|
|
organisation13
|
425 |
116K |
12 |
13/10/20 |
13/10/20 |
ASX - By Stock
|
425
|
116K
|
12
|
|
ASX - By Stock
|
SPA |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
organisation13
|
94 |
23K |
13 |
10/10/20 |
10/10/20 |
ASX - By Stock
|
94
|
23K
|
13
|
|
ASX - By Stock
|
DXN |
Re:
NSW Government Tender
|
|
organisation13
|
345 |
118K |
3 |
07/10/20 |
07/10/20 |
ASX - By Stock
|
345
|
118K
|
3
|
|
ASX - By Stock
|
DOU |
Re:
DOUUGH LIMITED DOU IPO Analysis
|
|
organisation13
|
81 |
47K |
8 |
06/10/20 |
06/10/20 |
ASX - By Stock
|
81
|
47K
|
8
|
|
ASX - By Stock
|
CDX |
Re:
Ann: Commercial Partnership with Mobvoi for New Health Smartwatch
|
|
organisation13
|
425 |
116K |
23 |
06/10/20 |
06/10/20 |
ASX - By Stock
|
425
|
116K
|
23
|
|
ASX - By Stock
|
CDX |
Re:
Ann: Commercial Partnership with Mobvoi for New Health Smartwatch
|
|
organisation13
|
425 |
116K |
20 |
25/09/20 |
25/09/20 |
ASX - By Stock
|
425
|
116K
|
20
|
|
ASX - By Stock
|
SPA |
Re:
Ann: Amazon to Sell SPACETALK in the UK
|
|
organisation13
|
75 |
14K |
4 |
23/09/20 |
23/09/20 |
ASX - By Stock
|
75
|
14K
|
4
|
|
ASX - By Stock
|
CDX |
Re:
CDX - Most Undervalued Company on ASX ?
|
|
organisation13
|
32 |
11K |
9 |
21/09/20 |
21/09/20 |
ASX - By Stock
|
32
|
11K
|
9
|
|
ASX - By Stock
|
CDX |
CDX - Most Undervalued Company on ASX ?
|
|
organisation13
|
32 |
11K |
27 |
19/09/20 |
19/09/20 |
ASX - By Stock
|
32
|
11K
|
27
|
|
ASX - By Stock
|
CDX |
Re:
Ann: CardieX Granted New Blood Pressure Patent
|
|
organisation13
|
21 |
5.9K |
11 |
18/09/20 |
18/09/20 |
ASX - By Stock
|
21
|
5.9K
|
11
|
|
ASX - By Stock
|
CDX |
Re:
Technical 200dma bullish cross
|
|
organisation13
|
466 |
131K |
18 |
18/09/20 |
18/09/20 |
ASX - By Stock
|
466
|
131K
|
18
|
|
ASX - By Stock
|
CDX |
Re:
Technical 200dma bullish cross
|
|
organisation13
|
466 |
131K |
13 |
17/09/20 |
17/09/20 |
ASX - By Stock
|
466
|
131K
|
13
|
|
ASX - By Stock
|
CDX |
Re:
Technical 200dma bullish cross
|
|
organisation13
|
466 |
131K |
9 |
17/09/20 |
17/09/20 |
ASX - By Stock
|
466
|
131K
|
9
|
|
ASX - By Stock
|
CDX |
Re:
Ann: Response to ASX Accounts Query
|
|
organisation13
|
6 |
2.8K |
18 |
16/09/20 |
16/09/20 |
ASX - By Stock
|
6
|
2.8K
|
18
|
|